ABSTRACT
Methylphenidate (MPD) remains a cornerstone pharmacological intervention for managing ADHD, yet its increasing usage among ordinary youth and adults outside clinical contexts necessitates a thorough investigation into its developmental effects. This study seeks to simultaneously investigate the behavioral and neuronal changes within the dorsal raphe (DR) nucleus, a center of serotonergic neurons in the mammalian brain, before and after the administration of varying doses of acute and chronic MPD in freely behaving young and adult rats implanted with DR recording electrodes. Wireless neuronal and behavioral recording systems were used over 10 consecutive experimental days. Eight groups were examined: saline, 0.6, 2.5, and 10.0 mg/kg MPD for both young and adult rats. Six daily MPD injections were administered on experimental days 1 to 6, followed by a three-day washout period and MPD re-administration on experimental day 10 (ED10). The analysis of neuronal activity recorded from 504 DR neurons (DRNs) in young rats and 356 DRNs in adult rats reveals significant age-dependent differences in acute and chronic MPD responses. This study emphasizes the importance of aligning electrophysiological evaluations with behavioral outcomes following extended MPD exposure, elucidating the critical role of DRNs and serotonin signaling in modulating MPD responses and delineating age-specific variations in young versus adult rat models.
Subject(s)
Behavior, Animal , Dorsal Raphe Nucleus , Methylphenidate , Serotonin , Animals , Methylphenidate/pharmacology , Dorsal Raphe Nucleus/drug effects , Dorsal Raphe Nucleus/metabolism , Rats , Serotonin/metabolism , Male , Behavior, Animal/drug effects , Neurons/drug effects , Neurons/metabolism , Serotonergic Neurons/drug effects , Serotonergic Neurons/metabolism , Rats, Sprague-Dawley , Signal Transduction/drug effects , Age FactorsABSTRACT
Birth stress is a risk factor for psychiatric disorders and associated with exaggerated release of the stress hormone arginine vasopressin (AVP) into circulation and in the brain. In perinatal hippocampus, AVP activates GABAergic interneurons which leads to suppression of spontaneous network events and suggests a protective function of AVP on cortical networks during birth. However, the role of AVP in developing subcortical networks is not known. Here we tested the effect of AVP on the dorsal raphe nucleus (DRN) 5-hydroxytryptamine (5-HT, serotonin) system in male and female neonatal rats, since early 5-HT homeostasis is critical for the development of cortical brain regions and emotional behaviors. We show that AVP is strongly excitatory in neonatal DRN: it increases excitatory synaptic inputs of 5-HT neurons via V1A receptors in vitro and promotes their action potential firing through a combination of its effect on glutamatergic synaptic transmission and a direct effect on the excitability of these neurons. Furthermore, we identified two major firing patterns of neonatal 5-HT neurons in vivo, tonic regular firing and low frequency oscillations of regular spike trains and confirmed that these neurons are also activated by AVP in vivo. Finally, we show that the sparse vasopressinergic innervation in neonatal DRN originates exclusively from cell groups in medial amygdala and bed nucleus of stria terminalis. Hyperactivation of the neonatal 5-HT system by AVP during birth stress may impact its own functional development and affect the maturation of cortical target regions, which may increase the risk for psychiatric conditions later on.
Subject(s)
Animals, Newborn , Arginine Vasopressin , Dorsal Raphe Nucleus , Serotonergic Neurons , Animals , Arginine Vasopressin/metabolism , Arginine Vasopressin/pharmacology , Female , Serotonergic Neurons/drug effects , Serotonergic Neurons/physiology , Male , Dorsal Raphe Nucleus/drug effects , Dorsal Raphe Nucleus/metabolism , Dorsal Raphe Nucleus/physiology , Rats , Action Potentials/drug effects , Action Potentials/physiology , Rats, Sprague-Dawley , Serotonin/metabolism , Excitatory Postsynaptic Potentials/drug effects , Excitatory Postsynaptic Potentials/physiology , Receptors, Vasopressin/metabolism , Synaptic Transmission/drug effects , Synaptic Transmission/physiologyABSTRACT
Tetrabromobisphenol-A-bis(2,3-dibromopropyl ether) (TBBPA-BDBPE), a novel additive brominated flame retardant, is being developed for use in polyolefin and copolymers. Despite its emerging application, the neurotoxicity and mechanisms of action of TBBPA-BDBPE remain unexplored. Caenorhabditis elegans was utilized as the model organism to study the neurotoxic effects of TBBPA-BDBPE across environmental concentrations ranging from 0 to 100 µg/L. This investigation focused on various toxicological endpoints such as locomotive behavior, neuronal injury, neurotransmitter transmission, and the regulation of nervous system-related gene expression. Acute exposure to TBBPA-BDBPE at concentrations of 10-100 µg/L significantly impaired nematode movement, indicating potential neurotoxicity. In transgenic nematodes, this exposure also caused damage to γ-aminobutyric acid (GABAergic) and serotonergic neurons, along with notable changes in the levels of GABAergic and serotonergic neurotransmitters. Further molecular studies indicated alterations in neurotransmission-related genes (cat-4, mod-1, unc-25, and unc-47). Molecular docking analysis confirmed the binding affinity of TBBPA-BDBPE to key neurotransmission proteins-CAT-4, MOD-1, UNC-25, and UNC-47. These findings demonstrate that TBBPA-BDBPE exerts neurotoxic effects by impacting GABAergic and serotonergic neurotransmission in nematodes. This study provides new insights into the potential environmental risks of TBBPA-BDBPE.
Subject(s)
Caenorhabditis elegans , Flame Retardants , Molecular Docking Simulation , Polybrominated Biphenyls , Synaptic Transmission , Animals , Caenorhabditis elegans/drug effects , Caenorhabditis elegans/genetics , Caenorhabditis elegans/physiology , Polybrominated Biphenyls/toxicity , Synaptic Transmission/drug effects , Flame Retardants/toxicity , Halogenated Diphenyl Ethers/toxicity , Serotonergic Neurons/drug effects , GABAergic Neurons/drug effects , GABAergic Neurons/metabolismABSTRACT
Cessation of therapy with a selective serotonin (5-HT) reuptake inhibitor (SSRI) is often associated with an early onset and disabling discontinuation syndrome, the mechanism of which is surprisingly little investigated. Here we determined the effect on 5-HT neurochemistry of discontinuation from the SSRI paroxetine. Paroxetine was administered repeatedly to mice (once daily, 12 days versus saline controls) and then either continued or discontinued for up to 5 days. Whereas brain tissue levels of 5-HT and/or its metabolite 5-HIAA tended to decrease during continuous paroxetine, levels increased above controls after discontinuation, notably in hippocampus. In microdialysis experiments continuous paroxetine elevated hippocampal extracellular 5-HT and this effect fell to saline control levels on discontinuation. However, depolarisation (high potassium)-evoked 5-HT release was reduced by continuous paroxetine but increased above controls post-discontinuation. Extracellular hippocampal 5-HIAA also decreased during continuous paroxetine and increased above controls post-discontinuation. Next, immunohistochemistry experiments found that paroxetine discontinuation increased c-Fos expression in midbrain 5-HT (TPH2 positive) neurons, adding further evidence for a hyperexcitable 5-HT system. The latter effect was recapitulated by 5-HT1A receptor antagonist administration although gene expression analysis could not confirm altered expression of 5-HT1A autoreceptors following paroxetine discontinuation. Finally, in behavioural experiments paroxetine discontinuation increased anxiety-like behaviour, which partially correlated in time with the measures of increased 5-HT function. In summary, this study reports evidence that, across a range of experiments, SSRI discontinuation triggers a rebound activation of 5-HT neurons. This effect is reminiscent of neural changes associated with various psychotropic drug withdrawal states, suggesting a common unifying mechanism.
Subject(s)
Mice, Inbred C57BL , Paroxetine , Selective Serotonin Reuptake Inhibitors , Serotonin , Substance Withdrawal Syndrome , Animals , Selective Serotonin Reuptake Inhibitors/pharmacology , Paroxetine/pharmacology , Serotonin/metabolism , Male , Substance Withdrawal Syndrome/metabolism , Mice , Hippocampus/drug effects , Hippocampus/metabolism , Receptor, Serotonin, 5-HT1A/metabolism , Receptor, Serotonin, 5-HT1A/drug effects , Hydroxyindoleacetic Acid/metabolism , Microdialysis , Serotonergic Neurons/drug effects , Serotonergic Neurons/metabolism , Brain/drug effects , Brain/metabolism , Neurons/drug effects , Neurons/metabolismABSTRACT
In the central nervous system, noradrenaline transmission controls the degree to which we are awake, alert, and attentive. Aberrant noradrenaline transmission is associated with pathological forms of hyper- and hypo-arousal that present in numerous neuropsychiatric disorders often associated with dysfunction in serotonin transmission. In vivo, noradrenaline regulates the release of serotonin because noradrenergic input drives the serotonin neurons to fire action potentials via activation of excitatory α1-adrenergic receptors (α1-AR). Despite the critical influence of noradrenaline on the activity of dorsal raphe serotonin neurons, the source of noradrenergic afferents has not been resolved and the presynaptic mechanisms that regulate noradrenaline-dependent synaptic transmission have not been described. Using an acute brain slice preparation from male and female mice and electrophysiological recordings from dorsal raphe serotonin neurons, we found that selective optogenetic activation of locus coeruleus terminals in the dorsal raphe was sufficient to produce an α1-AR-mediated excitatory postsynaptic current (α1-AR-EPSC). Activation of inhibitory α2-adrenergic receptors (α2-AR) with UK-14,304 eliminated the α1-AR-EPSC via presynaptic inhibition of noradrenaline release, likely via inhibition of voltage-gated calcium channels. In a subset of serotonin neurons, activation of postsynaptic α2-AR produced an outward current through activation of GIRK potassium conductance. Further, in vivo activation of α2-AR by systemic administration of clonidine reduced the expression of c-fos in the dorsal raphe serotonin neurons, indicating reduced neural activity. Thus, α2-AR are critical regulators of serotonin neuron excitability.
Subject(s)
Dorsal Raphe Nucleus , Locus Coeruleus , Receptors, Adrenergic, alpha-2 , Serotonergic Neurons , Synaptic Transmission , Animals , Dorsal Raphe Nucleus/drug effects , Dorsal Raphe Nucleus/physiology , Dorsal Raphe Nucleus/metabolism , Male , Receptors, Adrenergic, alpha-2/metabolism , Receptors, Adrenergic, alpha-2/physiology , Receptors, Adrenergic, alpha-2/drug effects , Locus Coeruleus/drug effects , Locus Coeruleus/physiology , Female , Serotonergic Neurons/drug effects , Serotonergic Neurons/physiology , Synaptic Transmission/drug effects , Synaptic Transmission/physiology , Mice , Excitatory Postsynaptic Potentials/drug effects , Excitatory Postsynaptic Potentials/physiology , Optogenetics , Adrenergic alpha-2 Receptor Agonists/pharmacology , Mice, Inbred C57BL , Norepinephrine/metabolism , Mice, TransgenicABSTRACT
Serotonergic psychedelics are emerging therapeutics for psychiatric disorders, yet their underlying mechanisms of action in the brain remain largely elusive. Here, we developed a wide-field behavioral tracking system for larval zebrafish and investigated the effects of psilocybin, a psychedelic serotonin receptor agonist. Machine learning analyses of precise body kinematics identified latent behavioral states reflecting spontaneous exploration, visually-driven rapid swimming, and irregular swim patterns following stress exposure. Using this method, we found that acute psilocybin treatment has two behavioral effects: [i] facilitation of spontaneous exploration ("stimulatory") and [ii] prevention of irregular swim patterns following stress exposure ("anxiolytic"). These effects differed from the effect of acute SSRI treatment and were rather similar to the effect of ketamine treatment. Neural activity imaging in the dorsal raphe nucleus suggested that psilocybin inhibits serotonergic neurons by activating local GABAergic neurons, consistent with psychedelic-induced suppression of serotonergic neurons in mammals. These findings pave the way for using larval zebrafish to elucidate neural mechanisms underlying the behavioral effects of serotonergic psychedelics.
Subject(s)
Anti-Anxiety Agents , Behavior, Animal , Hallucinogens , Psilocybin , Serotonergic Neurons , Zebrafish , Animals , Psilocybin/pharmacology , Behavior, Animal/drug effects , Hallucinogens/pharmacology , Anti-Anxiety Agents/pharmacology , Serotonergic Neurons/drug effects , Larva/drug effects , Swimming , Dorsal Raphe Nucleus/drug effects , Serotonin Receptor Agonists/pharmacology , Anxiety/drug therapy , GABAergic Neurons/drug effects , Selective Serotonin Reuptake Inhibitors/pharmacology , Ketamine/pharmacology , Brain/drug effectsABSTRACT
No abstract available.